Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Apitegromab Treatment in Children Under 2 Years Old with Spinal Muscular Atrophy (SMA)

    Recruiting

    1 1
    Investigated drugs:
    Belgium France Italy The Netherlands Spain
  • Study of Clenbuterol vs Placebo in Adult Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

    Recruiting

    1 1
    Investigated drugs:
    Italy
  • Study on the Safety and Pharmacokinetics of Risdiplam in Infants with Spinal Muscular Atrophy

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Italy The Netherlands Norway Poland
  • Study on the Early Use of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland
  • Study on the Effectiveness and Safety of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Germany Poland
  • Study on the Safety and Tolerability of BIIB115 for Children with Spinal Muscular Atrophy Previously Treated with Gene Therapy

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Poland
  • Long-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark France Italy The Netherlands Spain
  • Study on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy

    Not recruiting

    1 1 1
    Belgium Croatia France Germany Italy The Netherlands +3
  • Study of NMD670 tablets to improve muscle strength in adults with Type 3 spinal muscular atrophy who can walk

    Not recruiting

    Investigated drugs:
    Belgium Denmark Germany Italy The Netherlands Spain
  • Study on Long-Term Safety and Effects of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Trials

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Poland +1